BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

JSJ Pharmaceuticals, Inc. Announces Authorized Generic Agreement


4/4/2007 11:50:26 AM

CHARLESTON, S.C., April 4 /PRNewswire/ -- JSJ Pharmaceuticals is pleased to announce that, as part of its long-term brand life cycle management, it has reached an agreement with an undisclosed generic pharmaceutical partner to provide authorized generic versions of JSJ brands. While such an arrangement is important to the late stages of a brand's life cycle, it is critical that long-term planning is in place for rapid strategic execution. "At some point, a brand will lose its market exclusivity; an authorized generic partner provides JSJ with an important tool in the late-stage life cycle management of its brands and will let us respond quickly to changes in market conditions," stated JSJ's Chief Operating Officer, Jonathan Alba.

About JSJ:

JSJ Pharmaceuticals is a growing specialty pharmaceutical company focused on the development and commercialization of prescriptive products to meet the diverse needs of patients suffering from a wide range of dermatological conditions. More information can be found about JSJ Pharmaceuticals at http://www.jsjpharm.com.

Media Contact: Jon Knowles 843.965.8333 ext.104 jknowles@jsjpharm.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

JSJ Pharmaceuticals, Inc.

CONTACT: Jon Knowles of JSJ Pharmaceuticals, Inc., +1-843-965-8333ext.104, jknowles@jsjpharm.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES